Merck allergy drug deemed effective, safety questioned at FDA advisory meeting
This article was originally published in Scrip
Executive Summary
Merck & Co’s grass allergy tablet is effective, a panel of FDA advisers decided. But safety concerns linger for the immunotherapy.